You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 14, 2024

Litigation Details for ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for ASTRAZENECA AB v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-12-16 1 the ’504 patent expires on August 3, 2015. 13. United States Patent No. 6,369,085 (“the ’085… products covered by United States Patent Nos. 5,714,504; 6,369,085; 7,411,070; and 8,466,175. … The Patents-in-Suit 11. United States Patent No. 5,714,504 (“the ’504 patent”), entitled…formulations patented in the ’504 patent, is a material for use in practicing the methods patented in the ’…compounds patented in the ’085 patent, is a material for use in practicing the methods patented in the ’ External link to document
2015-06-05 12 Actavis admits that United States Patent No. 6,369,085 (the “’085 patent”) is entitled “Form of S-Omeprazole…Actavis admits that United States Patent No. 5,714,504 (“the ’504 patent”) is entitled “Compositions,” was… 1998 and, according to the patent assignment database at the U.S. Patent and Trademark Office, was assigned… 2002 and, according to the patent assignment database at the U.S. Patent and Trademark Office, was assigned…Actavis admits that United States Patent No. 7,411,070 (the “’070 patent”) is entitled “Form of S-Omeprazole External link to document
2015-06-26 17 claims of U.S. Patent Nos. 5,714,504 (the “’504 patent”); 6,369,085 (the “’085 patent”); 7,411,070 (… (the “’070 patent”); and 8,466,175 (the “’175 patent”) (collectively, the “patents-in- suit”). Plaintiffs… purports to state a cause of action under the patent laws of the United States, 35 U.S.C. § 1, et seq…respect to the ’504, ’192, ’085, ’872, and ’070 patents. Plaintiffs deny the remaining allegations of …with respect to the ’504, ’085, ’070, and ’175 patents. Plaintiffs deny the remaining allegations of External link to document
2014-12-17 2 Astra Aktiebolag 2 US 6,369,085 B1 4/9/2002 … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…Pleading PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK… ____ Trademarks or X Patents. ( ____ the patent action involves 35 U.S.C. § 292.) DOCKET… AO120 Patent Form filed. (mak) (Entered: 12/22/2014) 17 December 2014 PACER Document External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.